These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25830833)

  • 1. Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction.
    Fernandez IE; Heinzelmann K; Verleden S; Eickelberg O
    Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1():S34-41. PubMed ID: 25830833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung transplantation in patients with interstitial lung disease/idiopathic pulmonary fibrosis].
    Murer C; Benden C
    Ther Umsch; 2016; 73(1):43-5. PubMed ID: 26884220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench side.
    Borensztajn K; Crestani B; Kolb M
    Respiration; 2013; 86(6):441-52. PubMed ID: 24356558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic pulmonary fibrosis.
    Adkins JM; Collard HR
    Semin Respir Crit Care Med; 2012 Oct; 33(5):433-9. PubMed ID: 23001798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.
    Glass DS; Grossfeld D; Renna HA; Agarwala P; Spiegler P; Kasselman LJ; Glass AD; DeLeon J; Reiss AB
    Respir Investig; 2020 Sep; 58(5):320-335. PubMed ID: 32487481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonalities between the pro-fibrotic mechanisms in COPD and IPF.
    Murray LA
    Pulm Pharmacol Ther; 2012 Aug; 25(4):276-80. PubMed ID: 21983244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Endotyping of Pulmonary Fibrosis.
    Goodwin AT; Jenkins G
    Chest; 2016 Jan; 149(1):228-37. PubMed ID: 26356594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe idiopathic pulmonary fibrosis: A clinical approach.
    Lipsi R; Mazzola D; Caminati A; Elia D; Lonati C; Harari S
    Eur J Intern Med; 2018 Apr; 50():20-27. PubMed ID: 29361476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease and lung transplantation.
    O'Beirne S; Counihan IP; Keane MP
    Semin Respir Crit Care Med; 2010 Apr; 31(2):139-46. PubMed ID: 20354927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on idiopathic pulmonary fibrosis.
    Margaritopoulos GA; Giannarakis I; Siafakas NM; Antoniou KM
    Panminerva Med; 2013 Jun; 55(2):109-20. PubMed ID: 23676953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible.
    Balestro E; Cocconcelli E; Tinè M; Biondini D; Faccioli E; Saetta M; Rea F
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation for interstitial lung diseases and pulmonary hypertension.
    Gottlieb J
    Semin Respir Crit Care Med; 2013 Jun; 34(3):281-7. PubMed ID: 23821503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.
    Naikawadi RP; Green G; Jones KD; Achtar-Zadeh N; Mieleszko JE; Arnould I; Kukreja J; Greenland JR; Wolters PJ
    Am J Respir Cell Mol Biol; 2020 Oct; 63(4):490-501. PubMed ID: 32551854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].
    Behr J
    Dtsch Med Wochenschr; 2012 Mar; 137(12):601-4. PubMed ID: 22415624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic lung allograft dysfunction in 2022, past and updates].
    Halitim P; Tissot A
    Rev Mal Respir; 2023 Apr; 40(4):324-334. PubMed ID: 36858879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.
    O'Dwyer DN; Armstrong ME; Kooblall M; Donnelly SC
    Expert Opin Ther Targets; 2015 Apr; 19(4):507-14. PubMed ID: 25530171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPF: new insight on pathogenesis and treatment.
    Harari S; Caminati A
    Allergy; 2010 May; 65(5):537-53. PubMed ID: 20121758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.